Kathy E. Manning bought Eli Lilly and Company (NYSE: LLY)
Kathy E. Manning (D-NC), a U.S. Representative, has disclosed 1 trade in Eli Lilly and Company (LLY) since 2022, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Kathy E. Manning bought $1,001 - $15,000 of Eli Lilly and Company (NYSE: LLY) on July 15, 2022. Since that trade, LLY is up +260.01% against the S&P 500 up +102.64%, an outperformance of +157.37%.
Data updated
Kathy E. Manning's LLY trades vs the price
LLY is up +260.01% since Kathy E. Manning bought on July 15, 2022, versus +102.64% for the S&P 500.
Performance since this trade
All Kathy E. Manning LLY trades
Kathy E. Manning & LLY trading FAQ
Is it legal for Kathy E. Manning to trade Eli Lilly and Company (LLY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Eli Lilly and Company (LLY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Kathy E. Manning buy LLY?
Kathy E. Manning disclosed a purchase of $1,001 - $15,000 of Eli Lilly and Company (LLY) on July 15, 2022, according to public STOCK Act filings.
How has LLY performed since Kathy E. Manning's trade?
Since Kathy E. Manning bought LLY on July 15, 2022, the stock is up +260.01%, versus +102.64% for the S&P 500 over the same period, an outperformance of +157.37%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional LLY trades?
Quantellect tracks every disclosed congressional trade in Eli Lilly and Company (LLY) on the Eli Lilly and Company congressional trading page, which aggregates filings across all members of Congress.
Kathy E. Manning's LLY tradesAll congressional filings for Eli Lilly and CompanyKathy E. Manning's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.